Aurinia Pharmaceuticals (AUPH) EPS (Basic) (2019 - 2026)
Aurinia Pharmaceuticals (AUPH) posted EPS (Basic) of $0.26 for Q1 2026, down 83.46% on a QoQ basis from $1.57 in Q4 2025, and up 54.44% year-over-year from $0.17 in Q1 2025.
Aurinia Pharmaceuticals (AUPH) EPS (Basic) (2019 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at $0.26 for Q1 2026.
- Quarterly EPS (Basic) rose 54.44% year-over-year to $0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.25 (up 685.46% YoY) and the FY2025 annual result came in at $2.14, up 5216.0% from the prior year.
- EPS (Basic) was $0.26 for Q1 2026 at Aurinia Pharmaceuticals, down from $1.57 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.57 in Q4 2025 and bottomed at -$0.27 in Q1 2022.
- A 5-year average of $0.07 and a median of -$0.06 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 48.58% — and 2025, when it jumped 15094.77%.
- Aurinia Pharmaceuticals' EPS (Basic) stood at -$0.18 in 2022, then retreated by 2.31% to -$0.19 in 2023, then surged by 105.5% to $0.01 in 2024, then surged by 15094.77% to $1.57 in 2025, then slumped by 83.46% to $0.26 in 2026.
- Business Quant data shows AUPH's EPS (Basic) at $0.26 in Q1 2026, $1.57 in Q4 2025, and $0.24 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.26 |
| Dec 31, 2025 | 1.57 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.17 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.10 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | -0.19 |
| Sep 30, 2023 | -0.09 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -0.18 |
| Sep 30, 2022 | -0.06 |
| Jun 30, 2022 | -0.25 |
| Mar 31, 2022 | -0.27 |
| Dec 31, 2021 | -0.26 |
| Sep 30, 2021 | -0.39 |
| Jun 30, 2021 | -0.37 |